filmarray
respiratori
panel
multiplex
vitro
diagnost
test
simultan
rapid
detect
pathogen
directli
nasopharyng
swab
np
sampl
contain
updat
instanc
redesign
assay
improv
upon
filmarray
respiratori
panel
rp
version
faster
run
time
organ
identifi
adenoviru
coronaviru
coronaviru
coronaviru
coronaviru
human
metapneumoviru
human
rhinovirusenteroviru
influenza
viru
influenza
viru
influenza
viru
influenza
viru
influenza
viru
b
parainfluenza
viru
parainfluenza
viru
parainfluenza
viru
parainfluenza
viru
respiratori
syncyti
viru
bordetella
pertussi
chlamydia
pneumonia
mycoplasma
pneumonia
two
new
target
includ
filmarray
middl
east
respiratori
syndrom
coronaviru
bordetella
parapertussi
studi
provid
data
multicent
evalu
prospect
collect
np
sampl
perform
compar
filmarray
rp
pcr
sequenc
overal
percent
agreement
filmarray
compar
test
demonstr
posit
percent
agreement
greater
detect
three
analyt
coronaviru
b
parapertussi
b
pertussi
filmarray
also
demonstr
neg
percent
agreement
analyt
note
adenoviru
assay
detect
genotyp
demonstr
increas
sensit
filmarray
repres
signific
improv
filmarray
rp
substanti
shorter
run
time
could
aid
diagnosi
respiratori
infect
varieti
clinic
scenario
length
stay
better
antimicrobi
stewardship
better
patient
cohort
prevent
nosocomi
infect
filmarray
respiratori
panel
rp
first
introduc
syndrom
multiplex
molecular
test
detect
virus
addit
viral
analyt
bacteria
made
avail
softwar
updat
fda
clearanc
new
indic
adenoviru
inclus
improv
addit
new
primer
addit
fda
clearanc
version
filmarray
rp
refer
henceforth
articl
current
commerci
avail
version
devic
public
paper
ie
filmarray
respiratori
panel
order
ensur
molecular
diagnost
assay
remain
clinic
relev
particularli
syndrom
assay
import
period
updat
test
incorpor
new
sequenc
inform
accommod
emerg
previous
unrecogn
strain
pathogen
end
biofir
diagnost
updat
filmarray
rp
product
ad
new
assay
broaden
test
detect
capabl
particularli
adenovirus
modifi
subset
assay
reflect
newli
avail
genet
sequenc
current
includ
analyt
improv
chemistri
enhanc
sensit
overal
inclus
new
analyt
new
test
also
decreas
run
time
min
versu
min
organ
detect
note
result
merscov
mask
filmarray
product
fda
clear
us
market
analyt
report
filmarray
respiratori
panel
product
sold
outsid
us
test
individu
demonstr
signssymptom
respiratori
infect
clear
us
fda
modifi
intend
use
aid
differenti
diagnosi
merscov
infect
case
meet
merscov
clinic
andor
epidemiolog
criteria
filmarray
ident
current
filmarray
rp
respect
specimen
type
handl
test
workflow
pouch
control
analysi
softwar
studi
data
present
prospect
multicent
clinic
evalu
perform
filmarray
residu
nasopharyng
swab
np
specimen
collect
viral
transport
medium
vtm
perform
compar
filmarray
rp
analyt
common
two
test
well
pcr
follow
bidirect
sequenc
b
parapertussi
merscov
circul
unit
state
time
studi
therefor
specimen
assum
neg
compar
test
perform
analyt
filmarray
test
approxim
l
specimen
subject
filmarray
test
accord
manufactur
instruct
sampl
process
occur
biosafeti
cabinet
oper
wear
glove
appropri
person
protect
equip
one
sampl
process
time
clean
work
area
done
accord
manufactur
instruct
filmarray
test
consist
autom
nucleic
acid
extract
revers
transcript
nucleic
acid
amplif
result
analysi
approxim
min
per
run
ie
per
specimen
filmarray
softwar
perform
autom
result
analysi
target
valid
run
report
detect
detect
either
intern
control
fail
softwar
automat
provid
result
invalid
panel
analyt
target
shown
tabl
two
new
filmarray
studi
conduct
investigativeuseonli
iuo
version
filmarray
ident
final
fdaclear
cemark
version
import
note
result
merscov
report
paper
avail
filmarray
version
product
compar
test
compar
test
consist
soc
filmarray
rp
test
perform
sourc
laboratori
analyt
common
filmarray
rp
filmarray
analyt
except
merscov
b
parapertussi
specimen
assum
neg
merscov
circul
unit
state
time
enrol
studi
b
parapertussi
two
pcr
assay
target
target
identifi
filmarray
follow
bidirect
sequenc
use
compar
method
nucleic
acid
extract
specimen
use
magna
pure
lc
total
nucleic
acid
kithigh
perform
roch
diagnost
indianapoli
realtim
pcr
compar
assay
valid
found
limit
detect
lod
equival
filmarray
assay
test
perform
biofir
blind
manner
compar
assay
result
consid
posit
bidirect
sequenc
result
adequ
qualiti
found
match
sequenc
expect
analyt
e
valu
lower
genbank
nucleotid
databas
basic
local
align
search
tool
blastn
default
set
specimen
consid
posit
sequenceconfirm
result
either
assay
result
discrep
analysi
filmarray
result
consid
true
posit
tp
true
neg
tn
agre
result
compar
method
discrep
analysi
ensu
result
discord
ie
falseposit
fp
falseneg
fn
result
suffici
specimen
volum
avail
discord
specimen
investig
use
combin
retest
filmarray
compar
method
well
test
addit
independ
molecular
assay
addit
analysi
adenoviru
target
specimen
also
test
combin
pcr
assay
target
dbp
penton
pol
gene
combin
bidirect
sequenc
analysi
result
standardofcar
test
one
studi
site
nch
use
adenoviru
laboratorydevelop
test
ldt
pcr
target
hexon
gene
describ
previous
note
perform
data
posit
percent
agreement
ppa
neg
percent
agreement
npa
present
paper
consist
unresolv
data
present
packag
insert
fdaclear
test
discrep
investig
provid
use
recalcul
perform
data
statist
analysi
exact
binomi
twosid
confid
interv
ci
calcul
perform
measur
accord
wilson
score
method
total
prospect
studi
specimen
collect
geographicallydemograph
divers
subject
popul
analyz
studi
overal
studi
includ
specimen
male
femal
subject
respect
specimen
pediatr
subject
specimen
children
age
year
age
year
adult
age
year
adult
age
year
major
specimen
obtain
hospit
subject
visit
emerg
depart
respect
obtain
subject
seen
outpati
set
filmarray
test
perform
total
specimen
met
inclus
criteria
initi
test
clinic
evalu
overal
success
rate
initi
test
specimen
test
unsuccess
due
incomplet
test
due
instrument
error
due
control
failur
eleven
specimen
success
retest
addit
anoth
specimen
later
exclud
protocol
reason
result
total
specimen
includ
data
analysi
summari
filmarray
find
filmarray
detect
least
one
analyt
specimen
test
yield
overal
posit
rate
shown
tabl
highest
detect
rate
seen
young
children
year
age
rel
preval
analyt
among
posit
specimen
detect
filmarray
present
tabl
preval
organ
detect
studi
hrvev
rsv
adenoviru
flua
found
specimen
respect
taken
togeth
coronavirus
third
preval
target
detect
flua
merscov
target
posit
analyt
detect
occur
prospect
sampl
set
analyt
detect
fewer
specimen
summari
perform
characterist
individu
filmarray
target
present
tabl
compar
analysi
discrep
investig
total
analyz
filmarray
organ
result
specimen
overal
percent
agreement
filmarray
compar
test
detect
organ
result
filmarray
compar
method
posit
analyt
overal
ppa
respect
compar
method
result
detect
filmarray
compar
method
neg
analyt
overal
npa
respect
compar
method
use
compar
test
result
truth
fp
detect
fn
detect
overal
addit
discrep
analysi
perform
sampl
fp
case
fn
case
support
evid
filmarray
result
bring
adjud
overal
concord
posit
neg
result
respect
summari
discrep
investig
present
tabl
viral
analyt
filmarray
detect
total
viral
analyt
use
compar
result
truth
overal
ppa
npa
respect
result
sever
analyt
signific
interest
detail
adenoviru
signific
increas
detect
observ
comparison
filmarray
rp
total
detect
fp
fp
specimen
suffici
volum
retest
filmarray
rp
see
origin
result
anomali
possibl
specimen
also
test
combin
pcrsequenc
assay
target
dbp
n
penton
n
pol
n
gene
result
nch
ldt
assay
n
combin
investig
found
addit
evid
adenoviru
presenc
fp
specimen
tabl
specimen
late
amplif
filmarray
test
suggest
low
level
analyt
specimen
four
fp
specimen
filmarray
rp
retest
posit
also
late
amplif
suggest
low
level
analyt
also
fn
result
adenoviru
addit
discrep
analysi
specimen
includ
retest
filmarray
combin
pcr
assay
describ
avail
nch
ldt
result
adenoviru
combin
investig
found
addit
evid
adenoviru
presenc
three
four
fn
specimen
analysi
fn
specimen
filmarray
retest
posit
indic
late
amplif
suggest
low
analyt
level
fn
adenoviru
speci
c
base
sequenc
analysi
comprehens
summari
adenoviru
discord
analysi
provid
tabl
among
coronavirus
one
four
target
demonstr
good
perform
ppa
npa
except
demonstr
ppa
major
fn
specimen
observ
due
known
crossreact
compar
method
see
biofir
filmarray
rp
packag
insert
http
filmarray
rpdetect
result
coronaviru
due
crossreact
suspect
whenev
filmarray
rp
report
detect
crossreact
correct
redesign
assay
filmarray
six
eight
filmarray
fn
specimen
tp
ie
codetect
report
filmarray
rp
suggest
known
crossreact
state
previous
merscov
detect
cohort
note
npa
indic
lack
crossreact
coronavirus
data
archiv
merscov
specimen
contriv
merscov
sampl
provid
manufactur
packag
insert
filmarray
data
present
base
compar
assay
reflect
discord
analysi
b
term
ppa
posit
percent
agreement
npa
neg
percent
agreement
use
instead
sensit
specif
indic
nongold
standard
compar
eg
pcr
use
analysi
flua
target
show
fp
fn
detect
howev
posit
detect
flua
studi
period
predomin
flua
flub
two
fp
detect
confirm
investig
tp
flua
flua
flua
flua
result
exclud
analys
three
specimen
due
initi
result
influenza
equivoc
influenza
subtyp
detect
either
filmarray
filmarray
rp
test
insuffici
specimen
volum
retest
detect
hrvev
numer
total
highest
detect
trial
fp
result
fn
result
specimen
suffici
volum
retest
filmarray
rp
filmarray
possibl
specimen
also
test
combin
five
pcr
assay
target
utr
gene
fp
sampl
posit
filmarray
rp
retest
late
amplif
specimen
suggest
low
level
analyt
four
posit
pcr
assay
fn
sampl
four
specimen
posit
filmarray
repeat
test
one
posit
pcr
assay
three
four
fn
specimen
filmarray
retest
posit
late
amplif
suggest
low
level
analyt
rsv
detect
total
make
second
common
analyt
eight
fp
specimen
observ
contain
rsv
independ
molecular
method
retest
filmarray
rp
may
miss
soc
filmarray
rp
test
due
estim
hundredfold
differ
lod
filmarray
rp
filmarray
use
compar
result
truth
overal
ppa
npa
respect
bacteri
target
number
detect
bacteri
target
low
except
pneumonia
n
tabl
two
bacteri
analyt
demonstr
ppa
low
preval
b
parapertussi
n
b
pertussi
n
bacteri
target
tend
singl
analyt
detect
b
pertussi
c
pneumonia
pneumonia
copathogen
present
b
parapertussi
six
detect
context
codetect
one
virus
sampl
two
bacteri
target
detect
discord
analysi
bacteri
target
shown
tabl
studi
filmarray
demonstr
perform
test
larg
prospect
studi
residu
np
sampl
result
gener
data
signific
substanti
chang
result
rp
test
adopt
use
larg
number
clinic
laboratori
number
posit
detect
rel
high
organ
notabl
except
result
merscov
flua
circul
studi
popul
studi
period
filmarray
test
system
shown
reliabl
failur
success
initi
test
attempt
rapid
result
avail
approxim
min
shorter
filmarray
rp
approxim
min
run
time
data
present
along
test
archiv
posit
np
vtm
specimen
contriv
specimen
shown
use
part
regulatori
submiss
filmarray
receiv
k
clearanc
unit
state
ceivd
mark
european
union
june
filmarray
receiv
de
novo
clearanc
unit
state
novemb
period
updat
test
implement
import
concept
colleg
american
pathologist
cover
laboratorydevelop
test
microbiolog
checklist
state
laboratori
written
polici
procedur
evalu
nucleic
acid
test
compat
current
circul
microbi
strain
test
clear
fda
filmarray
repres
fourth
iter
multiplex
panel
sinc
introduct
provid
updat
primer
probe
base
reexamin
known
sequenc
major
pathogen
adjust
assay
condit
maxim
perform
note
signific
number
detect
found
rp
n
overal
design
goal
increas
sensit
analyt
rel
rp
may
account
signific
number
observ
fp
detect
support
lod
studi
report
product
insert
discord
analysi
perform
studi
increas
inclusivitysensit
decreas
time
result
min
filmarray
may
lead
improv
outcom
length
stay
proper
stewardship
warrant
studi
virus
common
caus
upper
respiratori
infect
adult
pediatr
popul
also
seen
studi
cohort
viral
detect
notabl
higher
bacteri
target
viral
detect
versu
bacteri
detect
filmarray
show
increas
posit
detect
rate
viral
target
comparison
filmarray
rp
detect
support
addit
discrep
investig
except
coronaviru
tabl
reflect
increas
sensit
inclus
filmarray
common
viral
analyt
hrvev
total
detect
versu
detect
filmarray
rp
increas
number
hrvev
detect
may
may
associ
true
diseas
causat
major
see
tabl
supplement
materi
context
codetect
viral
target
rhinoviru
report
commonli
detect
target
among
asymptomat
individu
rate
rang
depend
studi
filmarray
updat
broaden
inclus
chang
specif
hrvev
still
crossreact
enterovirus
henc
rhinovirusenteroviru
design
one
extens
modif
occur
detect
adenoviru
previou
studi
leber
et
al
demonstr
lack
sensit
filmarray
rp
adenoviru
type
f
despit
earlier
redesign
filmarray
rp
redesign
filmarray
specif
target
genotyp
includ
genotyp
f
typic
associ
respiratori
infect
type
b
c
e
cohort
genotyp
b
c
f
demonstr
detect
filmarray
detect
genotyp
import
particularli
immunocompromis
find
adenoviru
genotyp
np
vtm
may
preced
system
infect
addit
identif
speci
f
respiratori
specimen
report
patient
respiratori
ill
well
pediatr
patient
sampl
obtain
routin
adenoidectomytonsillectomi
overal
rel
low
number
bacteri
detect
filmarray
n
reason
like
due
true
diseas
preval
differ
studi
period
also
seen
data
tabl
codetect
bacteria
virus
common
particularli
b
pertussi
previous
report
target
gene
b
pertussi
filmarray
rp
filmarray
toxin
promot
region
singlecopi
gene
known
specif
commonli
use
insert
sequenc
gene
multicopi
target
present
sever
bordetella
speci
greater
specif
toxin
gene
target
may
less
sensit
report
previous
diagnosi
pertussislik
ill
improv
inclus
insert
sequenc
element
target
b
parapertussi
filmarray
b
parapertussi
known
caus
pertussislik
ill
cocircul
bordetella
speci
preval
b
parapertussi
uncertain
report
diseas
like
b
pertussi
test
commonli
pneumonia
common
bacteri
analyt
detect
filmarray
rp
howev
note
use
np
specimen
detect
pneumonia
may
suboptim
particularli
diagnos
lower
respiratori
tract
infect
overal
percentag
discrep
result
low
n
tabl
suggest
previou
version
filmarray
rp
rel
robust
perform
discrep
analysi
use
filmarray
rp
retest
pcr
bidirect
sequenc
confirm
fp
strong
evid
filmarray
increas
sensit
compar
filmarray
rp
limit
studi
prospect
studi
howev
sampl
frozen
less
prior
test
howev
data
indic
frozen
storag
significantli
affect
perform
studi
period
bridg
one
calendar
year
includ
two
partial
respiratori
season
variat
circul
strain
particularli
flua
limit
compar
method
target
filmarray
rp
data
concern
filmarray
perform
compar
amplifi
platform
cultur
provid
await
studi
final
lack
detect
merscov
flua
prospect
studi
limit
data
perform
target
signific
redesign
filmarray
demonstr
excel
sensit
specif
multicent
clinic
trial
import
step
individu
improv
pathogen
detect
recognit
manufactur
continu
improv
monitor
inclus
new
emerg
strain
speci
import
incorpor
design
filmarray
improv
perform
detect
infecti
agent
involv
respiratori
infect
chang
includ
new
target
merscov
b
parapertussi
improv
exist
target
decreas
time
result
improv
combin
simplic
test
process
shorter
time
result
make
filmarray
signific
improv
diagnost
test
supplement
materi
articl
may
found
http
supplement
file
pdf
file
mb
